Literature DB >> 23926244

Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section.

Hedvig E Jakobsson1, Thomas R Abrahamsson, Maria C Jenmalm, Keith Harris, Christopher Quince, Cecilia Jernberg, Bengt Björkstén, Lars Engstrand, Anders F Andersson.   

Abstract

OBJECTIVE: The early intestinal microbiota exerts important stimuli for immune development, and a reduced microbial exposure as well as caesarean section (CS) has been associated with the development of allergic disease. Here we address how microbiota development in infants is affected by mode of delivery, and relate differences in colonisation patterns to the maturation of a balanced Th1/Th2 immune response.
DESIGN: The postnatal intestinal colonisation pattern was investigated in 24 infants, born vaginally (15) or by CS (nine). The intestinal microbiota were characterised using pyrosequencing of 16S rRNA genes at 1 week and 1, 3, 6, 12 and 24 months after birth. Venous blood levels of Th1- and Th2-associated chemokines were measured at 6, 12 and 24 months.
RESULTS: Infants born through CS had lower total microbiota diversity during the first 2 years of life. CS delivered infants also had a lower abundance and diversity of the Bacteroidetes phylum and were less often colonised with the Bacteroidetes phylum. Infants born through CS had significantly lower levels of the Th1-associated chemokines CXCL10 and CXCL11 in blood.
CONCLUSIONS: CS was associated with a lower total microbial diversity, delayed colonisation of the Bacteroidetes phylum and reduced Th1 responses during the first 2 years of life.

Entities:  

Keywords:  Chemokines; Infant Gut; Intestinal Bacteria; Intestinal Microbiology; Molecular Biology

Mesh:

Substances:

Year:  2013        PMID: 23926244     DOI: 10.1136/gutjnl-2012-303249

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  319 in total

1.  Planned Cesarean Delivery at Term and Adverse Outcomes in Childhood Health.

Authors:  Mairead Black; Siladitya Bhattacharya; Sam Philip; Jane E Norman; David J McLernon
Journal:  JAMA       Date:  2015-12-01       Impact factor: 56.272

Review 2.  Prevention of Necrotizing Enterocolitis Through Manipulation of the Intestinal Microbiota of the Premature Infant.

Authors:  Kannikar Vongbhavit; Mark A Underwood
Journal:  Clin Ther       Date:  2016-02-09       Impact factor: 3.393

Review 3.  Efficacy of screening immune system function in at-risk newborns.

Authors:  Christopher J Pavlovski
Journal:  Australas Med J       Date:  2014-07-31

Review 4.  Role of the Microbiome in Food Allergy.

Authors:  Hsi-En Ho; Supinda Bunyavanich
Journal:  Curr Allergy Asthma Rep       Date:  2018-04-05       Impact factor: 4.806

5.  Chorioamnionitis exposure remodels the unique histone modification landscape of neonatal monocytes and alters the expression of immune pathway genes.

Authors:  Jennifer Bermick; Katherine Gallagher; Aaron denDekker; Steve Kunkel; Nicholas Lukacs; Matthew Schaller
Journal:  FEBS J       Date:  2018-12-22       Impact factor: 5.542

Review 6.  Gut microbiota and the development of pediatric diseases.

Authors:  Chun-Yi Lu; Yen-Hsuan Ni
Journal:  J Gastroenterol       Date:  2015-04-28       Impact factor: 7.527

Review 7.  Gut microbes and adverse food reactions: Focus on gluten related disorders.

Authors:  Heather J Galipeau; Elena F Verdu
Journal:  Gut Microbes       Date:  2014

Review 8.  Probiotics and necrotizing enterocolitis.

Authors:  Josef Neu
Journal:  Clin Perinatol       Date:  2014-09-30       Impact factor: 3.430

Review 9.  Evolutionary and developmental mismatches are consequences of adaptive developmental plasticity in humans and have implications for later disease risk.

Authors:  Peter D Gluckman; Mark A Hanson; Felicia M Low
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-04-15       Impact factor: 6.237

10.  Comparative analysis of the gut microbiota in distinct statin response patients in East China.

Authors:  Baoqing Sun; Luming Li; Xinfu Zhou
Journal:  J Microbiol       Date:  2018-11-27       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.